In Vivo Tumor Growth Control by General Control Nonderepressible 2-Targeting Agents Results from Kinase Activation

Area of Science:

• Molecular Biology
• Cellular Signaling
• Cancer Research

Background:

• General control nonderepressible 2 (GCN2) is a kinase involved in the integrated stress response.
• GCN2 inhibition shows promise for cancer treatment under nutrient stress.
• The role of GCN2 in cancer without nutrient stress is less understood.

Purpose of the Study:

• To investigate the dual role of GCN2 modulators (activation vs. inhibition) in cancer.
• To explore the therapeutic potential of GCN2 activation in cancer models.
• To elucidate the mechanism underlying GCN2-mediated effects on cell viability and tumor growth.

Main Methods:

• Biochemical and cell-based assays to assess GCN2 activity.
• In vitro and in vivo studies using GCN2-targeting agents.
• Knockdown and knockout experiments to confirm GCN2 dependence.
• Treatment with ISRIB to assess the role of translation initiation.

Main Results:

• Multiple GCN2 agents activate the kinase at low concentrations and inhibit at high concentrations.
• GCN2 activation, not inhibition, correlates with decreased cancer cell viability and tumor growth inhibition.
• GCN2-dependent activation of the integrated stress response is crucial for the observed effects.
• ISRIB abolished the viability effect, confirming dependence on translation initiation.
• Activating doses induced apoptosis markers (cleaved caspase 3 and PARP).

Conclusions:

• GCN2 activation, rather than inhibition, is a key mechanism for anti-cancer effects.
• The findings challenge the conventional understanding of GCN2 as solely an inhibitory target.
• This study provides critical insights for developing GCN2-targeting cancer therapies.
• Understanding the dual activity of GCN2 modulators is essential for clinical development.